5.75
price down icon5.89%   -0.36
pre-market  プレマーケット:  5.81   0.06   +1.04%
loading
前日終値:
$6.11
開ける:
$6.07
24時間の取引高:
44.87M
Relative Volume:
1.26
時価総額:
$2.46B
収益:
$64.60M
当期純損益:
$-377.75M
株価収益率:
-3.7097
EPS:
-1.55
ネットキャッシュフロー:
$-335.64M
1週間 パフォーマンス:
-15.32%
1か月 パフォーマンス:
+15.46%
6か月 パフォーマンス:
+2.13%
1年 パフォーマンス:
-13.01%
1日の値動き範囲:
Value
$5.58
$6.31
1週間の範囲:
Value
$5.58
$7.18
52週間の値動き範囲:
Value
$3.79
$12.36

Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile

Name
名前
Recursion Pharmaceuticals Inc
Name
セクター
Healthcare (1138)
Name
電話
(385) 269-0203
Name
住所
41S RIO GRANDE STREET, SALT LAKE CITY
Name
職員
800
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
RXRX's Discussions on Twitter

RXRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RXRX
Recursion Pharmaceuticals Inc
5.75 2.67B 64.60M -377.75M -335.64M -1.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.44 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.90 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
584.74 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
814.17 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.54 34.68B 4.56B -176.77M 225.30M -1.7177

Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-03 再開されました Morgan Stanley Equal-Weight
2023-05-22 開始されました Morgan Stanley Equal-Weight
2023-03-16 開始されました Needham Buy
2022-09-16 開始されました KeyBanc Capital Markets Overweight
2022-04-18 ダウングレード BofA Securities Buy → Neutral
2022-03-04 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-09-21 開始されました Berenberg Buy
2021-05-11 開始されました BofA Securities Buy
2021-05-11 開始されました Goldman Neutral
2021-05-11 開始されました JP Morgan Neutral
2021-05-11 開始されました KeyBanc Capital Markets Overweight
2021-05-11 開始されました SVB Leerink Outperform
すべてを表示

Recursion Pharmaceuticals Inc (RXRX) 最新ニュース

pulisher
06:59 AM

Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX) - Seeking Alpha

06:59 AM
pulisher
04:27 AM

Promising Biotech Stocks To ResearchOctober 19th - MarketBeat

04:27 AM
pulisher
04:24 AM

When is the best time to exit Recursion Pharmaceuticals Inc.Breakout Watch & Weekly Chart Analysis and Guides - newser.com

04:24 AM
pulisher
02:10 AM

Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com

02:10 AM
pulisher
Oct 22, 2025

Growth or Bubble? Decoding Recursion Pharmaceuticals Stock - StocksToTrade

Oct 22, 2025
pulisher
Oct 22, 2025

Recursion Pharmaceuticals Stock: Growth or Bubble? - StocksToTrade

Oct 22, 2025
pulisher
Oct 22, 2025

Top Biotech Stocks To Keep An Eye OnOctober 22nd - MarketBeat

Oct 22, 2025
pulisher
Oct 22, 2025

Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock” - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com

Oct 22, 2025
pulisher
Oct 22, 2025

Is it time to cut losses on Recursion Pharmaceuticals Inc.2025 Pullback Review & Expert Approved Momentum Ideas - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event - MSN

Oct 21, 2025
pulisher
Oct 21, 2025

Has Recursion Pharmaceuticals Inc. formed a bullish divergenceTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Why RXRX’s Stock Came Tumbling Down? - timothysykes.com

Oct 21, 2025
pulisher
Oct 21, 2025

What drives Recursion Pharmaceuticals Inc stock priceStock Price Divergence & Invest Like A Pro - earlytimes.in

Oct 21, 2025
pulisher
Oct 21, 2025

RXRX Stock’s Unexpected Surge: Analyzing Future Trends - StocksToTrade

Oct 21, 2025
pulisher
Oct 21, 2025

Top Biotech Stocks To ResearchOctober 21st - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Recursion Pharmaceuticals (RXRX) Surges 14% Ahead of Earnings - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

Up 25% in 1 Month, Is This Stock a Buy? - AOL.com

Oct 21, 2025
pulisher
Oct 21, 2025

Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN

Oct 21, 2025
pulisher
Oct 21, 2025

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Navigating the Biotech Frontier with a 33.3% Revenue Surge - DirectorsTalk Interviews

Oct 21, 2025
pulisher
Oct 21, 2025

How to recover losses in Recursion Pharmaceuticals Inc. stockForecast Cut & Advanced Swing Trade Entry Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Published on: 2025-10-20 23:47:28 - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Will Recursion Pharmaceuticals Inc. stock recover faster than marketInflation Watch & Expert Approved Trade Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionDay Trade & Real-Time Stock Price Movement Reports - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Lightning Round: Recursion Pharma is now a meme stock, says Jim Cramer - MSN

Oct 20, 2025
pulisher
Oct 20, 2025

Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.July 2025 Volume & Smart Investment Allocation Insights - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Recursion Pharmaceuticals Set for Further Gains After Recent 36% Share Price Surge? - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharmaceuticals (RXRX): Evaluating Valuation After AI Collaborations, Exscientia Deal, and Industry Leadership Moves - simplywall.st

Oct 20, 2025
pulisher
Oct 20, 2025

Custom strategy builders for tracking Recursion Pharmaceuticals Inc.Options Play & Expert-Curated Trade Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharmaceuticals Inc. stock volume spike explainedWeekly Stock Analysis & Daily Stock Trend Reports - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharma Stock Soars 16% on AI Buzz and Big Pharma Deals – Can RXRX Keep Climbing? - ts2.tech

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships - Quiver Quantitative

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares - The Motley Fool

Oct 20, 2025
pulisher
Oct 20, 2025

Why Recursion Pharmaceuticals Stock is Soaring - TipRanks

Oct 20, 2025
pulisher
Oct 20, 2025

AI in Biotechnology Research Report 2025: An $11.4 Billion - GlobeNewswire

Oct 20, 2025
pulisher
Oct 20, 2025

AI in Biotechnology Research Report 2025: An $11.4 Billion Market by 2030, Dominated by NVIDIA, Tempus AI, Recursion Pharmaceuticals, Schrodinger, and Sophia Genetics - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Recursion Pharmaceuticals call volume above normal and directionally bullish - TipRanks

Oct 20, 2025
pulisher
Oct 20, 2025

10 Big Names Beating Wall Street at its Own Game - Insider Monkey

Oct 20, 2025
pulisher
Oct 20, 2025

Will Recursion Pharmaceuticals Inc. stock maintain growth storyCEO Change & Daily Profit Maximizing Tips - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Recursion Pharmaceuticals Stock Analysis: Key Updates and Financial Overview - StocksToTrade

Oct 19, 2025
pulisher
Oct 19, 2025

Recursion (RXRX) Gains After Acquiring Exscientia and Expanding AI Pharma Partnerships Has the Risk Profile Shifted? - simplywall.st

Oct 19, 2025
pulisher
Oct 18, 2025

What analysts say about Recursion Pharmaceuticals Inc stockGeopolitical Risk Analysis & Small Budget Capital Gains - earlytimes.in

Oct 18, 2025
pulisher
Oct 18, 2025

Is Recursion Pharmaceuticals Inc. stock a top momentum playJuly 2025 Fed Impact & Free Reliable Trade Execution Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Market Moves: Is Recursion Pharmaceuticals Inc. stock a smart buy before Fed meetingJuly 2025 Setups & Safe Entry Trade Signal Reports - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Recursion Pharmaceuticals Hits Day High with 15.28% Surge in Stock Price - Markets Mojo

Oct 18, 2025
pulisher
Oct 17, 2025

Great Week for Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Institutional Investors After Losing 2.9% Over the Previous Year - 富途牛牛

Oct 17, 2025
pulisher
Oct 17, 2025

Is Recursion Pharmaceuticals a Millionaire Maker? - AOL.com

Oct 17, 2025
pulisher
Oct 16, 2025

Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights - sharewise.com

Oct 16, 2025
pulisher
Oct 16, 2025

Why Recursion Pharmaceuticals, Inc. (RXRX) Surged On Friday? - MSN

Oct 16, 2025
pulisher
Oct 16, 2025

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals - ts2.tech

Oct 16, 2025

Recursion Pharmaceuticals Inc (RXRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.84
price down icon 1.71%
$88.06
price up icon 0.87%
$29.92
price down icon 0.70%
$106.23
price down icon 0.62%
$160.40
price down icon 2.97%
biotechnology ONC
$313.54
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):